Here are four things to know:
1. Researchers conducted the population-based study using the Taiwan National Health Insurance database and the United Kingdom Clinical Practice Research Datalink. The study comprised 74,560 Taiwanese gout patients and 34,505 U.K. gout patients.
2. The TJR prevalence rates at the time of diagnosis were:
- Taiwan: 1.16 percent in gout patients, 0.82 percent in patients without gout
- U.K.: 2.61 percent in gout patients, 1.76 percent in patients without gout
3. After a gout diagnosis, the TJR incidence was higher in gout patients compared with patients who did not have gout in both nations.
4. Current urate-lowering treatment did not reduce the risk of TJR.
More articles on orthopedics:
Orthopedic surgeon to know: Dr. Lew Schon of MedStar Health
5 things to know about Connecticut Orthopaedic Institute at MidState Medical Center
15 orthopedic surgeons on the move
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.